§ Research summary · Regenerative

BPC-157 + TB-500 10/10 mg kit

Also known as · BPC / TB-500 blend · Wolverine blend

Regenerative·1 min read·reviewed 2026-05-07

The most-requested regenerative-peptide kit in the catalogue. BPC-157 and thymosin β-4 combined in a single lyophilised vial — commonly paired in preclinical tissue-repair research.

Chemistry quick-facts

Status
Both peptides are preclinical-only; no completed Phase 3 human clinical trials. Published literature is extensive in rodent models (BPC-157) and mixed preclinical / limited clinical for Tβ4.
Purity (HPLC)
≥ 99.0% (both peptides)

Mechanism of action

BPC-157: proposed modulation of nitric-oxide, VEGFR-2, and FAK–paxillin pathways. TB-500: G-actin sequestration, integrin-linked kinase upregulation, laminin-5 expression changes.

Research context

BPC-157 (Body Protection Compound 157) is a 15-residue pentadecapeptide fragment of a gastric-juice protein. Thymosin β-4 (TB-500) is a 43-residue actin-sequestering peptide abundant in mammalian tissues.

Both peptides have been studied independently in preclinical tissue-repair, wound-healing, and cytoskeletal-dynamics contexts. The blend format is a researcher convenience — two peptides reconstituted from one vial — not an endorsement of any specific combination protocol.

No human clinical trial has evaluated the BPC-157 / TB-500 combination. Supplied strictly for in vitro laboratory research.

Published studies

A non-exhaustive list of peer-reviewed studies referenced when curating this entry. Click through to the primary source for the full text.

  1. Sikirić P, et al. (2013). BPC 157 and NSAIDs — review. Current Pharmaceutical Design.
  2. Goldstein AL, et al. (2012). Thymosin β4 — basic properties and clinical applications. Expert Opinion on Biological Therapy.
  3. Seiwerth S, et al. (2021). Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Frontiers in Pharmacology.

Reconstitution

Solvent
Bacteriostatic water for injection (0.9% benzyl alcohol) — included with kit
Typical volume
1 – 2 mL
  • · Inject diluent slowly down the side of the vial onto the cake.
  • · Swirl gently — do not shake.
  • · Solution should be clear and colourless. Discard if not.

Storage

Lyophilised
−20 °C, desiccated, protected from light. Stable at 15–25 °C for up to 30 days in transit.
Reconstituted
2–8 °C, original vial, consumed within 4 weeks.
Shelf life — sealed
24 months from date of manufacture when stored lyophilised at −20 °C.

FAQ

Why combine the two in a single vial?+

Convenience only. Many preclinical tissue-repair protocols in the published literature use both peptides; pre-blending saves one reconstitution step.

Can the two be reconstituted separately?+

No — the blend is a single lyophilised cake containing both peptides. For separate-vial studies, order the individual SKUs.

Research-use disclaimer

This page summarises the research literature on BPC-157 + TB-500 10/10 mg kit for in vitro laboratory investigation only. It is not medical advice, not a treatment recommendation, and not a substitute for a qualified physician. Material is sold for analytical chemistry and cell-culture research, not for human or veterinary administration.

View BPC-157 + TB-500 10/10 mg kit in the catalogue →
§ Related reading